Idera Pharmaceuticals Inc (IDRA) Stock
IDRA is no longer traded. Idera Pharmaceuticals was delisted from the Nasdaq in January 2023.
Prices on this page are historical; the last trade was January 17, 2023 at $0.42.
Idera Pharmaceuticals stock price history
IDRA final trading statistics
- Final close
- $0.42
- Final trading day
- Jan 17, 2023
- Market cap at delisting
- $26.50M
- Shares outstanding
- 62.36M
- Final 52-week range
- $0.21 – $0.79
- Avg. volume (final 3 mo.)
- 174,250
- All-time high (split-adj.)
- $74119.86 · Jan 1996
- All-time low (split-adj.)
- $3.93 · Dec 2022
- Return since IPO
- -100.0%
- Beta
- 1.30
- Book value / share
- $0.35
- Price / book
- 1.21
Idera Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $0.00 | $98.1M | $39.44 |
| FY2020 | $0.00 | -$112.7M | -$36.96 |
| FY2019 | $1.45M | -$56.5M | -$2.94 |
| FY2018 | $662.0K | -$59.9M | -$2.27 |
| FY2017 | $902.0K | -$66.0M | -$3.36 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Idera Pharmaceuticals Inc
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
Idera Pharmaceuticals stock FAQ
What happened to Idera Pharmaceuticals stock?
Idera Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $0.42 on January 17, 2023.
Is IDRA stock still trading?
No. IDRA was delisted from the Nasdaq in January 2023 and no longer trades on a U.S. exchange.
What was the last price of IDRA stock?
IDRA closed at $0.42 on its final trading day, January 17, 2023, for a market value of about $26.50M.
What were Idera Pharmaceuticals's revenue and earnings in its last full fiscal year?
Idera Pharmaceuticals reported revenue of $0.00 and net income of $98.1M in fiscal 2021, its last full year as a public company.
When did Idera Pharmaceuticals go public?
Idera Pharmaceuticals Inc stock began trading on January 24, 1996.